The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations
Mariam Ibáñez(Instituto de Salud Carlos III), José Cervera(Instituto de Salud Carlos III), Eva Barragán(Hospital Universitari i Politècnic La Fe), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Jorge Jiménez(Centre for Biomedical Network Research on Rare Diseases), Maria López‐Pavía, Iván Martín(Universitat de València), Marta Llop(Hospital Universitari i Politècnic La Fe), José Carbonell‐Caballero(Centre for Genomic Regulation), Esperanza Such(Leitat Technological Center), Joaquı́n Dopazo(Fundación Progreso y Salud), Inés Gómez‐Seguí(Hospital Universitari i Politècnic La Fe), Pau Montesinos(Instituto de Salud Carlos III), Enrique Vidal(Leitat Technological Center), Luz García‐Alonso(Wellcome Sanger Institute)
Cited by 32
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Differential expression in RNA-seq: A matter of depth
|Genome Research|2011|1.7k